Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000460912 | SCV000548929 | likely benign | Adams-Oliver syndrome 5 | 2024-10-21 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001584157 | SCV001813391 | uncertain significance | not provided | 2023-05-16 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function |
Genome- |
RCV000460912 | SCV002553983 | uncertain significance | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002270497 | SCV002553984 | uncertain significance | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002411472 | SCV002676151 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2022-08-17 | criteria provided, single submitter | clinical testing | The p.G275S variant (also known as c.823G>A), located in coding exon 5 of the NOTCH1 gene, results from a G to A substitution at nucleotide position 823. The glycine at codon 275 is replaced by serine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |